[ad_1]
Patanjali Ayurved CEO, said Tuesday the firm gave all the information about your newly launched Covid-19 medicine of the Ministry of AYUSH. On Twitter, Acharya Balkrishna said that “the communication gap has been abolished”.
“This government provides the stimulus and pride to the Ayurveda. Communication gap has been abolished, and that we have 100% fulfilled with all the standard parameters for Randomized Placebo-Controlled Clinical Trials. We have given you the information of the same to the Ministry of AYUSH,” Balkrishna said on Twitter.
The AYUSH ministry on Tuesday asked yoga guru Ramdev Patanjali Ayurved to provide “to the first” the composition and other details of the medicine that is claimed for the treatment of COVID-19, and ordered the company to stop the advertising of the product until the “problem” is examined.
Patanjali Ayurved has launched the ‘Coronil and Swasari’ of the medicine with the claim that he has discovered a cure for the COVID-19.
However, the ministry said that the facts of the claim and the details of the scientific studies are not known to him.
Patanjali has also been asked for details of the sample size, sites and hospitals where the research study took place and the Institutional Ethics Committee clearance, the ministry said.
Yoga guru Ramdev’s herbal medicine of the company for Patanjali Ayurved Tuesday claimed to have discovered the cure for the coronavirus, but no medical authority could immediately respond to the claim of “Coronil and Swasari’ the medicine of the healing of the highly contagious disease within seven days.
The company said the two-Ayurved-based medicines have shown 100% good results during clinical trials in COVID-19 infected patients, except those in which a life support system.
Medicines have been developed by Patanjali Research Centre, Haridwar-owned and private National Institute of Medical Sciences, Jaipur, following all the protocols with a view-controlled, clinical trial-based evidence, Ramdev told PTI in a telephonic interaction with PTI.
“Patanjali was the first application of the clinical case and clinical conducted control trials following all of the protocols of drug discovery,” he said. Leaving aside questions about the drug being approved by the government agencies, such as icmr, Ramdev said controlled clinical study of these drugs is carried out in several cities as Delhi, Ahmedabad and Meerut, and the RCT (Randomized Clinical Trial, controlled with placebo, was conducted in Jaipur-based National Institute of Medical Sciences and Research.
The Crown kit, with a price of ₹545, would be available pan India within a week. The kit will have medications for 30 days. This is not an immunity booster, but a coronavirus cure, Ramdev, said. Manufactured by Haridwar based Divya Pharmacy and Patanjali Ayurved Ltd, the medicine is the result of a research collaboration between Patanjali Institute of Research and the Jaipur-based National Institute of Medical Sciences. Ramdev said that medicines can be ordered online through a mobile app from next Monday.
The COVID-19, the therapy suggested by Patanjali is applicable to adults ranging between 15-80 years of age, while children are recommended to take half the dose prescribed for adults. Patanjali anti-COVID tablet, Divya Coronil Tablet consists of Giloy, Tulsi and Ashwagandha and prescribed to take three times a day with warm water 30 minutes after breakfast, lunch and dinner.
With inputs from PTI
.
[ad_2]
